期刊文献+

乳腺癌EGF受体核素显像诊断和靶向治疗 被引量:2

Epidermal growth factor receptor nuclide imaging in diagnosis and targeting therapy for breast cancer
下载PDF
导出
摘要 目前临床上早期诊断及治疗乳腺癌的方法存在着各种局限性 ,非侵袭性表皮生长因子受体 (EGFR)介导的放射性核素显像诊断及核素靶向治疗 ,以其独到的功能显像和分子治疗展示了未来乳腺癌早期定性诊断和微创治疗的美好前景。现综述乳腺癌EGFR核素显像诊断和核素靶向治疗的研究进展。
出处 《国外医学(肿瘤学分册)》 2004年第12期925-928,共4页 Foreign Medical Sciences (Cancer Section)
基金 国家自然科学基金资助项目 (3 0 0 0 0 0 45 )
  • 相关文献

参考文献29

  • 1Azria D, Larbouret C, Robert B, et al. Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials. Bull Cancer,2003,90 Spec No:S202-212.
  • 2Kurebayashi J,Okubo S,Yamamoto Y,et al. Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer. Breast Cancer,2004,11 (1) :38-41.
  • 3Mass RD. The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys ,2004,58 (3) :932-940.
  • 4Thakur ML, Aruva MR, Gariepy J, et al. PET imaging of oncogene overexpression using 64Cu-Vasoactive Intestinal Peptide (VIP) analog: comparison with 99mTc-VIP analog. J Nucl Med ,2004,45 ( 8 ):1381-1389.
  • 5Bennink RJ,van Tienhoven G, Rijks LJ,et al. In vivo prediction of response to antiestrogen treatment in estrogen receptor-positive breast cancer. J Nucl Med ,2004,45( 1 ) :1-7.
  • 6Steiner K, Haunschild J, Faro HP, et al. Distribution of humanized MAb 425 (EMD 62,000) in rats and specific localization in tumorbearing nude mice. Cell Mol Biol (Noisy-lc-grand), 1995,41 (1):179-184.
  • 7Reilly RM, Kiarash R, Sandhu J, et al. A comparison of EGF and MAb 528 labeled with 111 In for imaging human breast cancer. J Nucl Med,2000,41 (5) :903-911.
  • 8Schechter NR,Yang DJ,Azhdarinia A,et al. Assessment of epidermal growth factor receptor with 99mTc-ethylenedicysteine-C225 monoclonal antibody. Anticancer Drugs ,2003,14 ( 1 ) :49-56.
  • 9Ramos Suzarte M, Rodriguez N, Oliva JP, et al. 99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part Ⅲ. Clinical trials safety and diagnostic efficacy. J Nucl Med, 1999,40(5 ) :768-775.
  • 10Wang J, Chen P, Mrkobrada M, et al. Antisense imaging of epidermal growth factor-induced p21 ( WAF-1/CIP-1 ) gene expression in MDA -MB-468 human breast cancer xenografts. Eur J Nucl Med Mol Imaging,2003,30(9): 1273-1280.

同被引文献19

  • 1徐丽莹,孔祥泉,徐海波,刘定西,于群,熊茵.早期乳腺癌动态增强MRI诊断[J].肿瘤防治研究,2004,31(10):617-618. 被引量:9
  • 2崔树德,张恒伟,刘慧.乳管镜对伴乳头溢液性疾病的诊断价值[J].中国实用外科杂志,2005,25(2):77-79. 被引量:26
  • 3Yamauchi H,Stearns V,Hayes DF.The Role of c-erbB-2 as a predictive factor in breast cancer[J].Breast Cancer,2001,8(3):171.
  • 4Winchester DP,Jeske JM,Goldschinidt RA.The diagnosis and management of ductal carcinoma in situ of the breast[J].CA Cancer J Clin,2000,50:184.
  • 5Kolb TM,Lichy J,Newhouse JH.Comparison of the performance of screeming mammopraghy,physical Examination,and breast US and evaluation of factors that influence them[J].An Analysis of 27825 Patient evaluations Radiology,2002,225:165.
  • 6Tozaki M,Kobayashi T,Uno S,et al.Brrest-converving surgery after chemotherapy:value of MDCT for detemining tunor distribution and shrinkiage pattem[J].AJR,2006,186 (2):431.
  • 7Izzo l,StasollaA,Basso L,et al.Characterization of tumoral lesions of the breast preliminary experience with multislice spiral CT[J].J Exp Clin Cancer Res,2005,24(2):209.
  • 8Aref M,Brechbiel M,Wiener EC,et al.Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents[J].Invest Radiol,2002,37(4):178.
  • 9Vargas HI,Romero L,Chlebowski RT.Management of bloody nipple discharge[J].Curr Treat Options Oncol,2002,3(2):157.
  • 10Verkooijen HM.Core Biopsy After Radiological Localisation (COBRA) Study Group Diagnostic acuuracy of stereotactic largecore needle biopsy for nonpalpable breast disease results of a multicenter prospective study with 95% surgical confirmation[J].Int J Cancer,2002,99:853.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部